PBU The Pension Fund of Early Childhood & Youth Educators raised its position in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 9.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 137,415 shares of the company’s stock after acquiring an additional 11,824 shares during the period. PBU The Pension Fund of Early Childhood & Youth Educators’ holdings in Colgate-Palmolive were worth $11,724,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp raised its stake in Colgate-Palmolive by 97.4% during the second quarter. State Street Corp now owns 94,195,992 shares of the company’s stock valued at $8,635,889,000 after purchasing an additional 46,476,510 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Colgate-Palmolive by 172.5% in the 1st quarter. Bank of New York Mellon Corp now owns 12,521,545 shares of the company’s stock worth $1,067,211,000 after buying an additional 7,927,238 shares during the last quarter. Bank of America Corp DE bought a new stake in shares of Colgate-Palmolive in the 2nd quarter worth about $567,483,000. Envestnet Asset Management Inc. raised its position in shares of Colgate-Palmolive by 266.5% during the 2nd quarter. Envestnet Asset Management Inc. now owns 4,146,337 shares of the company’s stock valued at $380,136,000 after buying an additional 3,014,860 shares in the last quarter. Finally, Assenagon Asset Management S.A. raised its position in shares of Colgate-Palmolive by 151.4% during the 3rd quarter. Assenagon Asset Management S.A. now owns 4,276,774 shares of the company’s stock valued at $364,894,000 after buying an additional 2,575,530 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several research analysts recently commented on the company. Royal Bank Of Canada lifted their price target on Colgate-Palmolive from $104.00 to $105.00 and gave the stock an “outperform” rating in a research report on Monday, November 2nd. Weiss Ratings lowered shares of Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 2nd. BNP Paribas Exane reiterated an “outperform” rating and set a $108.00 price objective (up from $97.00) on shares of Colgate-Palmolive in a research report on Monday, November 2nd. Barclays increased their target price on shares of Colgate-Palmolive from $87.00 to $95.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 3rd. Finally, Sanford C. Bernstein restated a “market perform” rating on shares of Colgate-Palmolive in a report on Thursday, August 13th. Thirteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $101.22.
View Our Latest Research Report on CL
Insider Activity at Colgate-Palmolive
In other news, COO Panagiotis Tsourapas sold 19,938 shares of the business’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $98.74, for a total transaction of $1,968,678.12. Following the completion of the sale, the chief operating officer directly owned 9,111 shares of the company’s stock, valued at approximately $899,620.14. The trade was a 68.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Gregory Malcolm sold 4,100 shares of the company’s stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $97.97, for a total transaction of $401,677.00. Following the completion of the transaction, the executive vice president owned 10,061 shares in the company, valued at approximately $985,676.17. The trade was a 28.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 77,414 shares of company stock valued at $7,613,786 over the last ninety days. Company insiders own 0.43% of the company’s stock.
Colgate-Palmolive Trading Down 0.2%
Shares of NYSE CL opened at $97.84 on Friday. Colgate-Palmolive Company has a fifty-two week low of $75.96 and a fifty-two week high of $101.18. The company has a debt-to-equity ratio of 11.23, a quick ratio of 0.63 and a current ratio of 0.96. The company has a market cap of $77.77 billion, a price-to-earnings ratio of 38.37, a PEG ratio of 4.44 and a beta of 0.31. The business’s 50 day moving average price is $90.74 and its 200-day moving average price is $90.22.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings data on Friday, October 30th. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.93 by $0.04. The company had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.34 billion. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. Colgate-Palmolive’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 EPS. On average, sell-side analysts expect that Colgate-Palmolive Company will post 3.92 earnings per share for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be given a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 83.14%.
About Colgate-Palmolive
Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
